LumiraDx Investor Presentation Deck slide image

LumiraDx Investor Presentation Deck

1 Introducing High Sensitivity Respiratory Testing with Ultra => Results in 5 minutes TH SARS-COV-2 Ag Ultra lumiraDx™ O High sensitivity: COVID Ultra PPA 97.4% at Ct <34 Fast results: 5 minutes from sample application Full respiratory pipeline: COVID, Flu A/B, RSV, Strep A Grouping Ct < 34 (all) Ct < 33 (all) Ct < 30 (all) Ct < 25 (all) N 39 38 35 25 Copyright © 2022 LumiraDx Ltd. All Rights Reserved. Worldwide PPA 97.4% 97.4% 97.1% 100% 26
View entire presentation